Mirtazapine
Product Images NDC 53002-1474

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 53002-1474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021474)

Mirtazapine 15mg tablets packaging label from RPK Pharmaceuticals, Inc. The label indicates a bottle containing 30 tablets with directions to take one tablet by mouth or as directed. Includes areas for patient name, prescribing information, lot number, and expiration date, as well as warnings about drowsiness, alcohol use, and operating machinery.*

FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

Chemical structure diagram depicting the molecular framework of the active ingredient mirtazapine, showing multiple rings including a pyridine and diazepine ring system with a methyl group attached to a nitrogen atom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.